STREAMEX CORP. Debt Instrument, Fair Value Disclosure
STREAMEX CORP. (STEX) had Debt Instrument, Fair Value Disclosure of $0 as of 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFairValue · last filed 2026-05-14
- 2026-03-31: Debt Instrument, Fair Value Disclosure $0.00.
- 2025-12-31: Debt Instrument, Fair Value Disclosure $38.00M.
| Period end | Debt Instrument, Fair Value Disclosure |
|---|---|
| 2026-03-31 | $0.00 10-Q · filed 2026-05-14 |
| 2025-12-31 | $38.00M 10-K · filed 2026-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B |